Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in NXTC — NextCure, Inc.

CIK 1214717 BOSTON, MA
Back to NXTC Full portfolio

Position in NXTC

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$47,847
-$284,214 QoQ
Shares Held
29,905
-3.8% QoQ
Ownership
0.653%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 30 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NXTC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. NXTC ranks #480 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in NXTC

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $47,847 29,905
2026-03-31 $332,061 31,092
2025-12-31 $328,597 23,157
2025-09-30 $114,392 19,521
2025-06-30 $105,664 229,707
2025-03-31 $113,368 236,185
2024-12-31 $180,346 233,914
2024-09-30 $306,524 223,741
2024-06-30 $311,526 195,929
2024-03-31 $389,596 174,707
2023-12-31 $199,165 174,707
2023-09-30 $225,372 174,707
2023-06-30 $283,647 157,582
2023-03-31 $249,384 168,503
2022-12-31 $237,589 168,503
2022-09-30 $464,287 168,832
2022-06-30 $803,732 171,007
2022-03-31 $737,801 151,811
2021-12-31 $858,047 143,008
2021-09-30 $947,367 140,559
2021-06-30 $1,086,619 135,320
2021-03-31 $2,505,843 250,334
2020-12-31 $2,036,218 186,809
2020-09-30 $1,771,783 201,339
2020-06-30 $4,387,417 204,637
2020-03-31 $6,793,151 183,252